Kate Lingard

Kate Lingard has a diverse and extensive work experience in the field of clinical research and project management. Kate recently joined Novotech as an Associate Project Director in 2021. Prior to that, they worked at Metro North Health as the Deputy Chair MNHA and as a Member (f) of the Human Research Ethics Committee. Kate also held the role of an Associate Director of Clinical Development at Actinogen Medical in 2021.

In their previous roles, Kate served as a Project Manager at Southern Star Research, where they managed various projects. Kate also worked as a Clinical Operations Manager at ResApp Health, where they oversaw global observational studies and managed multiple indications.

Before that, Kate worked at QBiotics Group Limited as the Manager of Human Clinical Operations, where they managed First-In-Human PhI/IIA clinical trials and contributed to product development plans. Kate also served as a Project Officer in Drug Development at QBiotics Group Limited.

In addition, Kate has experience as an Adjunct Tutor at The University of Queensland and as a Clinical Research Associate at Quintiles and Novotech. Throughout their career, they have demonstrated strong skills in project management, protocol design, clinical study report writing, budget development, and vendor management.

Overall, Kate Lingard has a well-rounded background in clinical research and project management, with expertise in various aspects of the field, including clinical operations, study design, and regulatory compliance.

Kate Lingard completed their Bachelor of Biotechnology Innovation (Hons) degree at QUT (Queensland University of Technology) from 2005 to 2008. Their studies focused on human and plant genetics, drug development, and business subjects such as marketing and strategy.